Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
304.49
-11.43 (-3.62%)
At close: Dec 5, 2025, 4:00 PM EST
304.20
-0.29 (-0.10%)
After-hours: Dec 5, 2025, 7:49 PM EST

Company Description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.

The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface.

It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy.

The company sells its products to end-users through the pharmacy channel; and independent distributors.

Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Insulet Corporation
Insulet logo
Country United States
Founded 2000
IPO Date May 15, 2007
Industry Medical Devices
Sector Healthcare
Employees 3,900
CEO Ashley McEvoy

Contact Details

Address:
100 Nagog Park
Acton, Massachusetts 01720
United States
Phone 978 600 7000
Website insulet.com

Stock Details

Ticker Symbol PODD
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001145197
CUSIP Number 45784P101
ISIN Number US45784P1012
Employer ID 04-3523891
SIC Code 3841

Key Executives

Name Position
Ashley A. McEvoy Chief Executive Officer, President and Director
Flavia H. Pease Executive Vice President and Chief Financial Officer
Eric Benjamin Executive Vice President and Chief Operating Officer
John Wodick Kapples J.D. Senior Vice President and General Counsel
Amit Guliani Chief Technology Officer
Clare Trachtman Vice President of Investor Relations
Laetitia Cousin Senior Vice President of Regulatory Affairs, Quality Assurance and Compliance
Angela Geryak Wiczek Senior Director of Corporate Communications
Philip Hildale Senior Vice President of Sales and Customer Care
Andrew Isaacson Senior Vice President of Strategy and Corporate Development

Latest SEC Filings

Date Type Title
Nov 26, 2025 144 Filing
Nov 24, 2025 144 Filing
Nov 6, 2025 10-Q Quarterly Report
Nov 6, 2025 8-K Current Report
Oct 30, 2025 SCHEDULE 13G/A Filing
Oct 23, 2025 8-K Current Report
Sep 16, 2025 144 Filing
Sep 16, 2025 8-K Current Report
Sep 8, 2025 144 Filing
Sep 8, 2025 144 Filing